Dr Reddy’s receives USFDA EIR report for formulations manufacturing facilities in Duvvada, Visakhapatnam, ET HealthWorld

[Pelican Press 0]

This is the hidden content, please

• Sign In
• or
• Sign Up

Dr Reddy’s receives USFDA EIR report for formulations manufacturing facilities in Duvvada, Visakhapatnam, ET HealthWorld

data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///ywAAAAAAQABAAACAUwAOw==

Hyderabad: Dr Reddy’s wrote to the National Stock Exchange of India Ltd (NSE) on the intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 – Update on the US FDA inspection at the company’s formulations manufacturing facilities (FTO-7 & FTO-9) in Duvvada, Visakhapatnam.

The company was intimated on May 17, 2024, on the inspection conducted by the ******* States Food & ***** Administration (US FDA) at the company’s formulations manufacturing facilities in Duvvada, Visakhapatnam, the company received the establishment inspection report (EIR).

The USFDA has classified the inspection as voluntary action indicated (VAI) and concluded that the inspection is ‘closed’ under 21 CFR 20.64(d)(3).

• Published On Aug 12, 2024 at 04:57 PM IST

Join the community of 2M+ industry professionals

Subscribe to our newsletter to get latest insights & analysis.

data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///ywAAAAAAQABAAACAUwAOw==

Download ETHealthworld App

• Get Realtime updates
• Save your favourite articles

data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///ywAAAAAAQABAAACAUwAOw==

data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///ywAAAAAAQABAAACAUwAOw==

Scan to download App
data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///ywAAAAAAQABAAACAUwAOw==

This is the hidden content, please

• Sign In
• or
• Sign Up

#Reddys #receives #USFDA #EIR #report #formulations #manufacturing #facilities #Duvvada #Visakhapatnam #HealthWorld

This is the hidden content, please

• Sign In
• or
• Sign Up

This is the hidden content, please

• Sign In
• or
• Sign Up